Alpha DNA Investment Management’s Veritone VERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-62,933
Closed -$1.41M 158
2021
Q4
$1.41M Buy
+62,933
New +$1.62M 0.89% 91
2021
Q2
Sell
-29,009
Closed -$695K 634
2021
Q1
$695K Buy
29,009
+3,305
+13% +$118K 0.8% 36
2020
Q4
$731K Buy
+25,704
New +$445K 0.78% 58

Other funds holding VERI

Alpha DNA Investment Management's VERI Position: Q1 2022 in Review

Alpha DNA Investment Management sold out of Veritone (VERI) in Q1 2022, closing a stake of 62,933 shares — an estimated $1.41M sold.

Alpha DNA Investment Management first reported a position in VERI in Q4 2020 and held it in 3 quarters. The position peaked at $1.41M in Q4 2021. 117 funds tracked by Wall St. Rank hold VERI as of Q1 2022.

  • Alpha DNA Investment Management reported no remaining Veritone position as of Q1 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 62,933 Veritone shares in Q1 2022, an estimated $1.41M.
  • Alpha DNA Investment Management first reported a position in Veritone in Q4 2020 and held it in 3 quarters.
  • Alpha DNA Investment Management's Veritone position peaked at $1.41M in Q4 2021.
  • 117 funds tracked by Wall St. Rank held Veritone as of Q1 2022.

Based on Alpha DNA Investment Management's 13F filing for Q1 2022, filed 13 May 2022.